Home > Insider Trading > Filing (0001104659-19-039167)

Filing Details

Accession Number:: 0001104659-19-039167
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-02 21:45:18
Reporting Period:: 2019-06-28

Accepted Time:: 2019-07-02 21:45:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1467154	Novan Inc.	NOVN	Pharmaceutical Preparations (2834)	204427682

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673063	Malin Corp Plc	2 Harbour Square, Crofton Road Dun Laoghaire, Co., Dublin L2		No	No	Yes	No
1685138	Ltd Holdings Sciences Life Malin	2 Harbour Square, Crofton Road Dun Laoghaire, Co., Dublin L2		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-06-28	17,800	$2.69	2,605,685	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-07-01	913	$2.74	2,604,772	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2019-07-02	6,287	$2.75	2,598,485	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.65 to $2.83, inclusive. The reporting persons undertake to provide to Novan, Inc., any holder of Novan, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
Malin Life Sciences Holdings Ltd, the record holder of the shares, is a wholly owned subsidiary of Malin Corporation plc. Malin Corporation plc may be deemed to beneficially own the shares and may be deemed to share voting and dispositive power over these shares.
The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.73 to $2.75, inclusive. The reporting persons undertake to provide to Novan, Inc., any holder of Novan, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting persons undertake to provide to Novan, Inc., any holder of Novan, Inc. stock or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.